What are the latest clinical trials for CLL in 2026

CLLMay 17, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Latest Clinical Trials for CLL in 2026

I appreciate your question about current clinical trials. However, I need to be transparent about what I can tell you based on the medical guidelines available to me.

What I Can Share From Current Guidelines

The NCCN Guidelines (Version 1.2026, updated October 2025) that I have access to mention several treatment approaches that are being studied in clinical trials, though they don't provide a comprehensive list of all active 2026 trials. Here's what the guidelines highlight:

Active Research Areas in CLL:

1. CAR T-Cell Therapy

Lisocabtagene maraleucel (Tecartus) continues to show strong results in real-world use
In a recent analysis of 30 patients, this therapy achieved a 76% overall response rate with manageable side effects
The TRANSCEND CLL 004 study demonstrated this approach's effectiveness

2. Combination Therapies Being Studied:

BTK inhibitors + Immune checkpoint inhibitors (like nivolumab + ibrutinib)
Venetoclax-based combinations with targeted agents
These combinations are being evaluated for both newly diagnosed and treatment-resistant CLL

3. Richter Transformation Research

Multiple trials are testing new approaches for when CLL transforms to aggressive lymphoma, including:
- Pirtobrutinib (a newer BTK inhibitor)
- CAR T-cell therapy
- Combination checkpoint inhibitor strategies

How to Find Current 2026 Trials

Since clinical trial information changes frequently and new trials open regularly, I recommend:

✅ ClinicalTrials.gov - Search "chronic lymphocytic leukemia" and filter by:

Status: Recruiting or Active
Location: Your area
Phase: I, II, or III

✅ Your Oncology Team - They have real-time access to:

Trials at your treatment center
Trials you may be eligible for based on your specific CLL characteristics
Enrollment requirements and benefits

✅ Leukemia & Lymphoma Society - Maintains updated trial information and can connect you with resources

Questions to Ask Your Doctor About Trials

"Are there any clinical trials at this center that might be appropriate for my CLL?"
"Based on my specific CLL characteristics (mutations, stage, prior treatments), which trial approaches would be most relevant?"
"What are the potential benefits and risks of participating in a trial versus standard treatment?"
"How would a trial affect my current treatment plan?"

According to the NCCN Guidelines, enrollment in a clinical trial is often the preferred initial treatment option, particularly for complex cases or when standard approaches haven't worked.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →